Dectin-1 deficiency alleviates diabetic cardiomyopathy by attenuating macrophage-mediated inflammatory response

Area of Science:

• Immunology
• Cardiology
• Metabolic Diseases

Background:

• Cardiovascular diseases are a leading cause of death in diabetic and obese patients.
• Diabetes-induced hyperglycemia and hyperlipidemia impair cardiac function via inflammatory pathways.
• Dectin-1, a pattern recognition receptor on macrophages, is implicated in pro-inflammatory responses.

Purpose of the Study:

• To investigate the role of Dectin-1 in the development of diabetic cardiomyopathy.
• To determine if Dectin-1 deficiency protects against diabetes-induced cardiac dysfunction.

Main Methods:

• Assessed Dectin-1 expression in heart tissues of diabetic mice.
• Utilized Dectin-1-deficient mice subjected to STZ-induced type 1 diabetes and high-fat-diet-induced type 2 diabetes.
• Examined cardiac function, cardiomyocyte hypertrophy, fibrosis, and inflammation.
• Investigated Dectin-1's role in macrophage activation and inflammatory cytokine production in vitro.

Main Results:

• Dectin-1 expression was elevated in the hearts of diabetic mice, primarily on macrophages.
• Dectin-1-deficient mice showed protection against diabetes-induced cardiac dysfunction, hypertrophy, fibrosis, and inflammation.
• Dectin-1 deficiency reduced inflammatory cytokine induction in macrophages exposed to high glucose and palmitate.
• Reduced paracrine inflammatory factors from Dectin-1 deficient macrophages lessened cardiomyocyte hypertrophy and fibrotic responses.

Conclusions:

• Dectin-1 plays a critical role in mediating inflammation-driven diabetic cardiomyopathy.
• Targeting Dectin-1 presents a potential therapeutic strategy for managing diabetic cardiomyopathy.